Nuclear Drug for Therapeutic Market, Global Outlook and Forecast 2023-2029

Report ID: MMG175122 | Category: Pharma & Healthcare | Pages: 69 | Format: PDF | Published Date: August 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
This report aims to provide a comprehensive presentation of the global market for Nuclear Drug for Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Drug for Therapeutic. This report contains market size and forecasts of Nuclear Drug for Therapeutic in global, including the following market information:
Global Nuclear Drug for Therapeutic Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Nuclear Drug for Therapeutic market was valued at US$ 1719.4 million in 2022 and is projected to reach US$ 2152.8 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Therapeutic Nuclear Medicines key players include Bayer, Novartis AG, China Isotope & Radiation, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 46%, followed by Europe and Asia-Pac
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nuclear Drug for Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nuclear Drug for Therapeutic Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Nuclear Drug for Therapeutic Market Segment Percentages, by Type, 2022 (%)
    Radium-223
    Lutetium-177
    Iodine-131
    Other
Global Nuclear Drug for Therapeutic Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Nuclear Drug for Therapeutic Market Segment Percentages, by Application, 2022 (%)
    Thyroid
    Bone Metastasis
    Lymphoma
    Other
Global Nuclear Drug for Therapeutic Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Nuclear Drug for Therapeutic Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nuclear Drug for Therapeutic revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Nuclear Drug for Therapeutic revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Bayer
    Novartis
    China Isotope & Radiation
    Dongcheng
    Q BioMed
    Curium Pharmaceuticals
    Jubilant DraxImage
    Lantheus
    Spectrum Pharmaceuticals
    Progenics Pharmaceuticals
    International Isotopes
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nuclear Drug for Therapeutic, market overview.
Chapter 2: Global Nuclear Drug for Therapeutic market size in revenue.
Chapter 3: Detailed analysis of Nuclear Drug for Therapeutic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nuclear Drug for Therapeutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Nuclear Drug for Therapeutic Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Nuclear Drug for Therapeutic Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Nuclear Drug for Therapeutic Overall Market Size
    2.1 Global Nuclear Drug for Therapeutic Market Size: 2022 VS 2029
    2.2 Global Nuclear Drug for Therapeutic Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Nuclear Drug for Therapeutic Players in Global Market
    3.2 Top Global Nuclear Drug for Therapeutic Companies Ranked by Revenue
    3.3 Global Nuclear Drug for Therapeutic Revenue by Companies
    3.4 Top 3 and Top 5 Nuclear Drug for Therapeutic Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Nuclear Drug for Therapeutic Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Nuclear Drug for Therapeutic Players in Global Market
        3.6.1 List of Global Tier 1 Nuclear Drug for Therapeutic Companies
        3.6.2 List of Global Tier 2 and Tier 3 Nuclear Drug for Therapeutic Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Nuclear Drug for Therapeutic Market Size Markets, 2022 & 2029
        4.1.2 Radium-223
        4.1.3 Lutetium-177
        4.1.4 Iodine-131
        4.1.5 Other
    4.2 By Type - Global Nuclear Drug for Therapeutic Revenue & Forecasts
        4.2.1 By Type - Global Nuclear Drug for Therapeutic Revenue, 2018-2023
        4.2.2 By Type - Global Nuclear Drug for Therapeutic Revenue, 2024-2029
        4.2.3 By Type - Global Nuclear Drug for Therapeutic Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Nuclear Drug for Therapeutic Market Size, 2022 & 2029
        5.1.2 Thyroid
        5.1.3 Bone Metastasis
        5.1.4 Lymphoma
        5.1.5 Other
    5.2 By Application - Global Nuclear Drug for Therapeutic Revenue & Forecasts
        5.2.1 By Application - Global Nuclear Drug for Therapeutic Revenue, 2018-2023
        5.2.2 By Application - Global Nuclear Drug for Therapeutic Revenue, 2024-2029
        5.2.3 By Application - Global Nuclear Drug for Therapeutic Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Nuclear Drug for Therapeutic Market Size, 2022 & 2029
    6.2 By Region - Global Nuclear Drug for Therapeutic Revenue & Forecasts
        6.2.1 By Region - Global Nuclear Drug for Therapeutic Revenue, 2018-2023
        6.2.2 By Region - Global Nuclear Drug for Therapeutic Revenue, 2024-2029
        6.2.3 By Region - Global Nuclear Drug for Therapeutic Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Nuclear Drug for Therapeutic Revenue, 2018-2029
        6.3.2 US Nuclear Drug for Therapeutic Market Size, 2018-2029
        6.3.3 Canada Nuclear Drug for Therapeutic Market Size, 2018-2029
        6.3.4 Mexico Nuclear Drug for Therapeutic Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Nuclear Drug for Therapeutic Revenue, 2018-2029
        6.4.2 Germany Nuclear Drug for Therapeutic Market Size, 2018-2029
        6.4.3 France Nuclear Drug for Therapeutic Market Size, 2018-2029
        6.4.4 U.K. Nuclear Drug for Therapeutic Market Size, 2018-2029
        6.4.5 Italy Nuclear Drug for Therapeutic Market Size, 2018-2029
        6.4.6 Russia Nuclear Drug for Therapeutic Market Size, 2018-2029
        6.4.7 Nordic Countries Nuclear Drug for Therapeutic Market Size, 2018-2029
        6.4.8 Benelux Nuclear Drug for Therapeutic Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Nuclear Drug for Therapeutic Revenue, 2018-2029
        6.5.2 China Nuclear Drug for Therapeutic Market Size, 2018-2029
        6.5.3 Japan Nuclear Drug for Therapeutic Market Size, 2018-2029
        6.5.4 South Korea Nuclear Drug for Therapeutic Market Size, 2018-2029
        6.5.5 Southeast Asia Nuclear Drug for Therapeutic Market Size, 2018-2029
        6.5.6 India Nuclear Drug for Therapeutic Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Nuclear Drug for Therapeutic Revenue, 2018-2029
        6.6.2 Brazil Nuclear Drug for Therapeutic Market Size, 2018-2029
        6.6.3 Argentina Nuclear Drug for Therapeutic Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Nuclear Drug for Therapeutic Revenue, 2018-2029
        6.7.2 Turkey Nuclear Drug for Therapeutic Market Size, 2018-2029
        6.7.3 Israel Nuclear Drug for Therapeutic Market Size, 2018-2029
        6.7.4 Saudi Arabia Nuclear Drug for Therapeutic Market Size, 2018-2029
        6.7.5 UAE Nuclear Drug for Therapeutic Market Size, 2018-2029
7 Nuclear Drug for Therapeutic Companies Profiles
    7.1 Bayer
        7.1.1 Bayer Company Summary
        7.1.2 Bayer Business Overview
        7.1.3 Bayer Nuclear Drug for Therapeutic Major Product Offerings
        7.1.4 Bayer Nuclear Drug for Therapeutic Revenue in Global Market (2018-2023)
        7.1.5 Bayer Key News & Latest Developments
    7.2 Novartis
        7.2.1 Novartis Company Summary
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Nuclear Drug for Therapeutic Major Product Offerings
        7.2.4 Novartis Nuclear Drug for Therapeutic Revenue in Global Market (2018-2023)
        7.2.5 Novartis Key News & Latest Developments
    7.3 China Isotope & Radiation
        7.3.1 China Isotope & Radiation Company Summary
        7.3.2 China Isotope & Radiation Business Overview
        7.3.3 China Isotope & Radiation Nuclear Drug for Therapeutic Major Product Offerings
        7.3.4 China Isotope & Radiation Nuclear Drug for Therapeutic Revenue in Global Market (2018-2023)
        7.3.5 China Isotope & Radiation Key News & Latest Developments
    7.4 Dongcheng
        7.4.1 Dongcheng Company Summary
        7.4.2 Dongcheng Business Overview
        7.4.3 Dongcheng Nuclear Drug for Therapeutic Major Product Offerings
        7.4.4 Dongcheng Nuclear Drug for Therapeutic Revenue in Global Market (2018-2023)
        7.4.5 Dongcheng Key News & Latest Developments
    7.5 Q BioMed
        7.5.1 Q BioMed Company Summary
        7.5.2 Q BioMed Business Overview
        7.5.3 Q BioMed Nuclear Drug for Therapeutic Major Product Offerings
        7.5.4 Q BioMed Nuclear Drug for Therapeutic Revenue in Global Market (2018-2023)
        7.5.5 Q BioMed Key News & Latest Developments
    7.6 Curium Pharmaceuticals
        7.6.1 Curium Pharmaceuticals Company Summary
        7.6.2 Curium Pharmaceuticals Business Overview
        7.6.3 Curium Pharmaceuticals Nuclear Drug for Therapeutic Major Product Offerings
        7.6.4 Curium Pharmaceuticals Nuclear Drug for Therapeutic Revenue in Global Market (2018-2023)
        7.6.5 Curium Pharmaceuticals Key News & Latest Developments
    7.7 Jubilant DraxImage
        7.7.1 Jubilant DraxImage Company Summary
        7.7.2 Jubilant DraxImage Business Overview
        7.7.3 Jubilant DraxImage Nuclear Drug for Therapeutic Major Product Offerings
        7.7.4 Jubilant DraxImage Nuclear Drug for Therapeutic Revenue in Global Market (2018-2023)
        7.7.5 Jubilant DraxImage Key News & Latest Developments
    7.8 Lantheus
        7.8.1 Lantheus Company Summary
        7.8.2 Lantheus Business Overview
        7.8.3 Lantheus Nuclear Drug for Therapeutic Major Product Offerings
        7.8.4 Lantheus Nuclear Drug for Therapeutic Revenue in Global Market (2018-2023)
        7.8.5 Lantheus Key News & Latest Developments
    7.9 Spectrum Pharmaceuticals
        7.9.1 Spectrum Pharmaceuticals Company Summary
        7.9.2 Spectrum Pharmaceuticals Business Overview
        7.9.3 Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Major Product Offerings
        7.9.4 Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Revenue in Global Market (2018-2023)
        7.9.5 Spectrum Pharmaceuticals Key News & Latest Developments
    7.10 Progenics Pharmaceuticals
        7.10.1 Progenics Pharmaceuticals Company Summary
        7.10.2 Progenics Pharmaceuticals Business Overview
        7.10.3 Progenics Pharmaceuticals Nuclear Drug for Therapeutic Major Product Offerings
        7.10.4 Progenics Pharmaceuticals Nuclear Drug for Therapeutic Revenue in Global Market (2018-2023)
        7.10.5 Progenics Pharmaceuticals Key News & Latest Developments
    7.11 International Isotopes
        7.11.1 International Isotopes Company Summary
        7.11.2 International Isotopes Business Overview
        7.11.3 International Isotopes Nuclear Drug for Therapeutic Major Product Offerings
        7.11.4 International Isotopes Nuclear Drug for Therapeutic Revenue in Global Market (2018-2023)
        7.11.5 International Isotopes Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Nuclear Drug for Therapeutic Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?